HARTE HANKS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HARTE HANKS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	404	384	285	218	177	195	206	191	185	160
Selling, general and administrative				24.3	21.5	17.9	21.9	20.7	22.8	22.2
Operating expenses				222	174	178	188	80.2	79.4	72.1
Operating income	-53.8	-40.9	-26	-21.6	-10.6	7.64	15.1	3.36	2.09	0.39
Interest expense		0.3	0.2	0.9	0.7	0.5	0.3	0.2
Other non-operating income	-15.3	-10.9	25.5	-2.91	-7.73	8.62	4.21	-5.28	-40	-1.39
Pre-tax income	-69.1	-51.8	-0.56	-24.5	-18.3	16.3	19.3	-1.92	-37.9	-1.01
Income tax	20.6	-9.89	-18.1	1.75	-16.6	1.29	-17.5	-0.35	-7.64	-0.2
Income from continuing operations	-89.8	-41.9	17.6	-26.3
Net income	-131	-41.9	17.6	-26.3	-1.69	15	36.8	-1.57	-30.3	-0.81
EBITDA	-41.5	-30.4	-18.6	-16.3	-6.96	10.2	17.8	7.6	6.48	4.86
EPS, basic	-21.29	-6.76	2.39	-4.26	-0.34	1.85	4.98	-0.21	-4.15	-0.11
EPS, diluted	-21.29	-6.76	2.38	-4.26	-0.34	1.76	4.75	-0.21	-4.15	-0.11
Shares, basic (weighted)	6.15	6.19	6.24	6.28	6.47	6.8	7.1	7.31	7.29	7.39
Shares, diluted (weighted)	6.15	6.19	6.27	6.28	6.47	7.21	7.46	7.31	7.29	7.39
Dividend per share	0.85	0.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	46	8.4	20.9	28.1	29.4	11.9	10.4	18.4	9.81	5.58
Receivables	88.8	81.4	54.2	39	36	41.1	39.7	34.3	31.6	27.8
Inventory	0.84	0.59	0.45	0.35	0.05
Other current assets	4.93	3.9	2.54	1.67	0.89	1.03	1.61	0.93	1.37	2.05
Total current assets	149	103	105	79.3	86.2	75.4	66.3	65.2	53.6	46.3
Property, plant and equipment	23.9	21.8	13.6	8.32	5.88	7.75	10.5	8.86	8.96	8.39
Lease right-of-use assets				17.7	23.8	21.4	18.6	25.3	21.7	19.2
Goodwill	34.5	0	0			0	2.4	1.93	0.3	0.3
Intangible assets	3.3	2.59	0			0	3.54	2.82	0.56	0.37
Other non-current assets	2.27	3.23	6.59	3.76	2.63	2.6	1.74	1.26	0.72	0.56
Total assets	213	131	125	110	119	108	120	123	102	91.8
Accounts payable	45.6	36.1	31.1	16.9	16.3	16.1	22.5	23.2	13.4	13.1
Accrued liabilities	9.99	10.6	6.78	4.22	5.25	7.03	6.68	5.62	8.4	5.92
Deferred revenue	6.51	5.34	6.03	4.4	4.66	3.94	4.59	3.2	1.59	0.81
Short-term debt	0				4.93	0				0
Total current liabilities	105	67.2	54.2	45.5	47.2	42.4	43.6	48.1	35.1	30.2
Long-term debt	0	0	14.2	18.7	22.2	5	0
Lease liabilities				12.5			16.5	23.7	20.2	18.4
Other non-current liabilities	4.51	4.2	4.06	2.61	4.75	3.7	3.26	1.93	1.55	1.17
Total liabilities	211	165	135	150	163	123	101	103	80.1	71.3
Total debt	0	0	14.2	18.7	27.1	5	0
Paid-in capital	459	457	454	447	383	291	218	158	124	110
Retained earnings	837	795	813	798	796	811	846	845	815	814
Treasury stock	-1,259	-1,254	-1,251	-1,244	-1,179	-1,085	-1,010	-951	-916	-900
Other comprehensive income	-46.2	-44.3	-46.5	-63.1	-65.6	-53.3	-48.3	-44.1	-13.6	-15
Shareholders' equity	2.66	-34.6	-19.2	-49.7	-53.1	-24.7	18.8	19.9	21.7	20.5
Total equity	2.66	-34.6	-19.2	-49.7	-53.1	-24.7	18.8	19.9	21.7	20.5
Total liabilities and equity	213	131	125	110	119	108	120	123	102	91.8
Shares outstanding			6.26	6.3	6.6	6.98	7.4	7.22	7.36	7.41

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-131	-41.9	17.6	-26.3	-1.69	15	36.8	-1.57	-30.3	-0.81
Depreciation and amortization	12.4	10.5	7.45	5.34	3.62	2.56	2.73	4.24	4.39	4.47
Stock-based compensation	2.67	2.66	-0.58	1.07	0.76	1.47	2.36	1.42	1.93	0.26
Deferred income tax	26.3	-11	-1.65	1	-0.24	0	-19.8	-1.47	-9.28	-0.93
Change in receivables	14.9	7.42	7.47	16.8	-0.93	-9.18	3.84	5.65	2.39	4.97
Change in inventory	0.13	0.25	0.14	0.09	0.31
Change in payables	9.13	-10.4	9.25	-13.8	-1	-0.4	6.2	0.84	-0.8	-3.21
Cash from operations	14.6	-30.8	-9.18	12.1	-7.84	-1.76	28.8	10.5	-2.99	-1.74
Capital expenditures	-6.69	-5.68	-4.21	-2.9	-2.7	-3.05	-5.8	-2.81	-3.75	-2.76
Acquisitions	-3.5	0				0	-5.75	0.5	0
Cash from investing	99.7	-5.67	-0.05	-2.6	-0.78	-2.9	-11.5	-2.31	-3.74	-2.76
Debt issued	276	30	23.2	4.5	10	5	0
Debt repaid	-354	-30.2	-9	0	-1.6	-17.1	-5	0
Stock issued	-0.23	-0.11
Share buybacks	0	0					0	-2.37	0
Dividends paid	-5.29	0
Cash from financing	-85.3	-1.46	22.7	3.09	7.31	-13.4	-15.8	-3.22	-0.42	0.51
Exchange rate effect	0.44	0.32	-1.01	0.65	0.74	-0.35	-5.25	2.55	-1.78	-0.37
Net change in cash	29.4	-37.6	12.5	13.2	-0.56	-18.4	-3.77	7.5	-8.93	-4.35
Free cash flow	7.9	-36.5	-13.4	9.2	-10.5	-4.81	23	7.67	-6.73	-4.49
Interest paid	5.67	0.29	0.2	0.88	0.65	0.49	0.27	0.24	0.23	0.29
Income taxes paid	2.59	32.9	-0.12	19.4	9.22	1.32		2.9	1.45	1.78

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.60 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	-3.1%	Operating income / revenue.
EBITDA margin	-0.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-3.8%	Pre-tax income / revenue.
Net margin	-3.7%	Net income / revenue.
FCF margin	-0.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	0.8%	Cash from operations / revenue.
Return on equity (ROE)	-37.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-6.5%	Net income / average total assets.
Return on invested capital (ROIC)	-37.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	16.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.8%	Capital expenditures / revenue.
D&A / revenue	2.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-13.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-8.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-2.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-81.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-70.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-25.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-35.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	-5.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	-9.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-8.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-5.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	2.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.30x	Current assets / current liabilities.
Quick ratio	0.94x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.15x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	82.6%	Total liabilities / total assets.
Working capital	$10.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	0.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$14.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.76x	Revenue / average total assets.
Fixed asset turnover	22.5x	Revenue / average property, plant and equipment.
Receivables turnover	5.64x	Revenue / average receivables.
Days sales outstanding	65 days	365 x average receivables / revenue.
Capex / operating cash flow	212.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.77	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$20.81	Revenue / diluted weighted shares.
FCF per share	-$0.19	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.17	Cash from operations / diluted weighted shares.
Book value per share	$2.06	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.98	Tangible book value / shares outstanding.
Cash per share	$0.70	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$34.3M	Share price x shares outstanding.
Enterprise value	$29.1M	Market cap + total debt - cash - short-term investments.
P/S	0.22x	Market cap / revenue.
P/B	2.23x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.32x	Market cap / tangible book value, when positive.
P/OCF	26.7x	Market cap / cash from operations, when positive.
EV/Sales	0.19x	Enterprise value / revenue.
FCF yield	-4.2%	Free cash flow / market cap.
Earnings yield	-16.7%	Net income / market cap (the inverse of P/E).

What was HARTE HANKS INC's revenue in fiscal 2025?

HARTE HANKS INC reported revenue of $159.6M for fiscal 2025, 13.9% lower than the year before.

Was HARTE HANKS INC profitable in fiscal 2025?

No. It reported a net loss of $811.0K.

How much free cash flow did HARTE HANKS INC generate in fiscal 2025?

Cash from operations of $1.7M minus capital expenditures of $2.8M left free cash flow of -$4.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HARTE HANKS INC